Lei Ling

机构：Guangxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, First Affiliated Hospital of GuangXi Medical University · ORCID：0000-0001-6316-2128

发表论文 68 篇 · 总被引 385 次 · h-index 12

代表论文

• Strong, tough and anisotropic bioinspired hydrogels (2024 · Materials Horizons · 被引 78)
• Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer (2025 · Journal of Translational Medicine · 被引 21)
• Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p/TGFBR2 axis to affect the p38 MAPK/NF-κB pathway (2023 · Cytokine · 被引 20)
• Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer’s disease-like neuropathology and cognitive deficits (2023 · Aging · 被引 13)
• Design, synthesis of griseofamine A derivatives and development of potent antibacterial agents against MRSA (2024 · European Journal of Medicinal Chemistry · 被引 6)
• Dynamic changes in lysosome‐related pathways in APP/PS1 mice with aging (2024 · MedComm · 被引 5)